Literature DB >> 30370139

Visiting an old foe: distant recurrence following R0 lobectomy for pathological N0 lung adenocarcinoma.

Sameer A Hirji1, Thomas A D'Amico2.   

Abstract

Entities:  

Year:  2018        PMID: 30370139      PMCID: PMC6186634          DOI: 10.21037/jtd.2018.08.116

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.

Authors:  Kristin A Higgins; Junzo P Chino; Neal Ready; Thomas A D'Amico; Mark F Berry; Thomas Sporn; Jessamy Boyd; Chris R Kelsey
Journal:  J Thorac Oncol       Date:  2012-07       Impact factor: 15.609

2.  Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer.

Authors:  Chenxi Zhong; Feng Yao; Heng Zhao
Journal:  Ann Thorac Surg       Date:  2012-12-20       Impact factor: 4.330

3.  Tumor Size, Margin Distance Rate, and Margin Cytologic Results Influence Recurrence and Survival After Wedge Resection for Lung Cancer.

Authors:  Noriyoshi Sawabata
Journal:  Ann Thorac Surg       Date:  2016-03       Impact factor: 4.330

4.  Local failure after complete resection of N0-1 non-small cell lung cancer.

Authors:  Mert Saynak; Nirmal K Veeramachaneni; Jessica L Hubbs; Jiho Nam; Bahjat F Qaqish; Janet E Bailey; Wonil Chung; Lawrence B Marks
Journal:  Lung Cancer       Date:  2010-07-07       Impact factor: 5.705

5.  Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.

Authors:  Galal Ghaly; Mohamed Rahouma; Mohamed K Kamel; Abu Nasar; Sebron Harrison; Andrew B Nguyen; Jeffrey Port; Brendon M Stiles; Nasser K Altorki; Paul C Lee
Journal:  Ann Thorac Surg       Date:  2017-05-24       Impact factor: 4.330

6.  Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.

Authors:  Filippo Lococo; Alfredo Cesario; Stefano Margaritora; Valentina Dall'Armi; Dania Nachira; Giacomo Cusumano; Elisa Meacci; Pierluigi Granone
Journal:  Ann Thorac Surg       Date:  2012-04-04       Impact factor: 4.330

7.  Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Authors:  Alona Zer; Keyue Ding; Siow Ming Lee; Glenwood D Goss; Lesley Seymour; Peter M Ellis; Allan Hackshaw; Penelope A Bradbury; Lei Han; Christopher J O'Callaghan; Ming-Sound Tsao; Frances A Shepherd
Journal:  J Thorac Oncol       Date:  2015-12-31       Impact factor: 15.609

Review 8.  Lymphovascular invasion as a prognostic indicator in stage I non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Nathan M Mollberg; Carrie Bennette; Eric Howell; Leah Backhus; Beth Devine; Mark K Ferguson
Journal:  Ann Thorac Surg       Date:  2014-01-11       Impact factor: 4.330

9.  Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma.

Authors:  Whitney S Brandt; Ilies Bouabdallah; Kay See Tan; Bernard J Park; Prasad S Adusumilli; Daniela Molena; Manjit S Bains; James Huang; James M Isbell; Matthew J Bott; David R Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2017-11-13       Impact factor: 5.209

10.  Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer.

Authors:  Ching-Feng Wu; Jui-Ying Fu; Chi-Ju Yeh; Yun-Hen Liu; Ming-Ju Hsieh; Yi-Cheng Wu; Ching-Yang Wu; Ying-Huang Tsai; Wen-Chi Chou
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.